Cryoport's Partnership with Takeda's BioLife Plasma Services Aims to Change the World of Cellular Therapies for the Better

Cryoport and Cell Matters Collaboration Aids in the Standardization of Cell Therapy Supply Chain Processes

RegMedNet Highlights Cryoport’s First Two Global Supply Chain Centers

Cryoport Expands Global Supply Chain Network through Recent Acquisition of Cell&Co BioServices

New Global Supply Chain Center Launch Will Expand Cryoport's Presence in Houston Markets

Strategic Partnership between Cryoport and Cell Matters will Greatly Improve Cryopreservation Services

Mergermarket: Cryoport Continues Opportunistic Acquisition Drive to Build Upon Current Markets

The Future of Life Sciences Supply Chain Industry: 4G/5G Network Technology Adoption

In Light Of The Pandemic, Here Are The 5 Things We Need To Do To Improve The US Healthcare System - Authority Magazine

Cryoport Recognized as the King of Cool in Temperature-Controlled Logistics

Reshaping The Pharmaceutical Supply Chain - Contract Pharma Q&A

2021 Predictions for Regenerative Medicine as the Pandemic Continues

Bloomberg Interview: Cryoport, Inc. CEO Discusses Vaccine Distribution Complexities

Bringing New Efficiencies to the Animal Health Sector

Building A Patient-Centric Supply Chain for Cell and Gene Therapies

ISO 21973: Standardizing Best Practices for Transporting Cell and Gene Therapies

Navigating the New Normal in the Transportation Industry as the Pandemic Continues

Contract Pharma Features Cryoport Growth and Innovation

Life Sciences in 2020: Biospace Interviews Mark Sawicki on Impending Developments in Cell and Gene Therapy

The Future is Now: CCO Mark Sawicki Shares the Effects of New Technology on Cold Chain Logistics in Pharma Manufacturing

Cryoport-Lonza Partnership Featured in Contract Pharma and Biopharma Dive

New Cryoport Partnerships Featured in Biopharma-Reporter, Contract Pharma, and

As More Cell and Gene Therapies Go to Market, Manufacturing Challenges Abound: Cryoport’s Ryan Carpentier Predicts Important Industry Trends in Contract Pharma

Ryan Carpentier Discusses CAR T Therapy Successes and Challenges in Contract Pharma

New Cryoport-Vineti Partnership Provides Expanded Supply Chain Services for Cell and Gene Therapy Developers: Outsourcing Pharma, Pharmaceutical Commerce Publications

Life Science Leader Magazine Features Cryoport Board Member Robert Hariri, Stem Cell Research Pioneer and Celularity CEO

Cryoport’s Technology, Record-Breaking Q2 Earnings Featured in Outsourcing-Pharma

2019 Has Been The Most Significant Year in Cryoport History – And It’s Not Over Yet

Cryoport President and CEO Jerrell W. Shelton Discusses the ‘Robust Demand’ of the Cell Therapy Market with BioPharma-Reporter

Cryoport President and CEO Featured in The Digital Enterprise, Discussing Cryoport’s Leading Excellence in Logistics

Keeping Cell and Gene Therapies Alive in Transit - Technology Networks

Cryoport CEO discusses new Global Logistics Centre in Amsterdam - Gasworld

Cryoport Expands its Sources of Temperature-Controlled Logistics Solutions - Pharmaceutical Commerce

Cryoport Talks Compliance, Biopharma Expansion, and Brexit - Outsourcing-Pharma

Building an unbreakable Chain of Compliance® - BioPharma Dealmakers

Cryoport Tackles Market Needs with New NJ Facility - Contract Pharma

Why the Cold Chain is Striking Hot - ASIA Outlook

Expert Opinion: The Latest Insight on the Life Sciences Supply Chain - ASIA Outlook

Be The Match BioTherapies, Cryoport Enter Agreement - Contract Pharma

Quality Systems for Regenerative Medicine Delivery; Basic Quality Requirements for Distribution - World Pharma Today

Cryoport, World Courier Ink Logistics Deal for Gene Therapies - Logistics for the Life Sciences

The Chain of Compliance® - Contract Pharma

Exclusive interview with Cryoport CEO - Gasworld

Inside the Company Delivering the Next Generation of Cancer Therapies - Wired Magazine

The Logistics Behind Personalized Medicine Delivery - Contract Pharma Article

Understanding Pharmaceutical Logistics Validation in a Dynamic Environment - Pharmaceutical Outsourcing

CAR-T Supply Chain Logistics - Contract Pharma Article

Cryogenic Logistics Company Cryoport Grabs Contracts for Gilead, Novartis CAR-T Products - BioSpace Article

Intelligent Logistics: Key Considerations of Manufacturing Biologics

Cold Chain Market and Technology Trends

The Arrival of Quality by Design in Logistics

Packaging, IT and Cold Chain Logistics Advances for the Future of Medicine and Clinical Trials

Risky Move

Biostorage: Closing the Loop in Biopharmaceutical Supply Chain Management

IT and Logistics Solutions for Animal Vaccine Distribution

Cold Chain Planning: An Integrated Approach

Logistics Advancements and Trends in the Biopharma Industry

Cold Chain Challenges Evolving With Industry

Cold Chain Planning for Regenerative Medicine Clinical Studies

It’s Never Too Early for Cold Chain Planning for Cellular Therapies

The Complexity of Cold Chain Logistics

Cryoport Launching Logistics Study for Bioanalytical and Clinical Trial Materials

CenterWatch Interview: Cryoport’s Chief Commercial Officer, Mark W. Sawicki, Ph.D., on a New Era of Logistics Challenges

Cryoport to Convert Life Science Shipping Logistics For Contract Manufacturer

Supply Chain Challenges with New Therapies

The Best Chance of Delivery for Life-Giving Shipments

Cryogenic Gas Solutions Drive Regenerative Therapies in Life Sciences

Logistical Nightmare

Consequences of Using Non-Frozen Delivery Systems Putting Biopharmaceutical Cargo at Risk

Inside the Hidden Global Supply Chain for Frozen Sperm, Eggs and Embryos

Cold Chain: Going the Extra Mile

How Cold Chain Logistics Work in Clinical Trials

Cryogenic Cold Chain Risk Mitigation

Shipping Service Offers Cryogenic Transit and Storage

Cryoport® is a trademark of Cryoport, Inc. and used with permission by Cryoport Systems, LLC